Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNITY-1: Daclatasvir/Asunaprevir/Beclabuvir FDC in Non-cirrhotic HCV GT1
NCT01979939Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of beclabuvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Dec 2013; status: completed.
02
Drugs
beclabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01979939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979939.